• Learning Objective 1: Review the role of CGRP in migraine pathogenesis
  • Learning Objective 2: Review the current and emerging anti-CGRP agents and their use in treating migraine


Session date: 
11/05/2019 - 8:00am to 9:00am CST
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Lloyd S. Davis, MD